fatty liver disease

Olivia
Marketing

Meet Madrigal, which wants to be your liver's No. 1 fan

Madrigal is aiming to accomplish what has so far proven to be impossible: to bring a fatty liver drug across the FDA finish line and onto the market.
Ben Adams Nov 15, 2023 9:40am
liver NASH NAFLD

NASH market holds 'enormous untapped potential,' analysts say

Aug 10, 2023 10:00am
FDA stop sign

UPDATED: Intercept restructures as NASH hopes dashed by FDA

Jun 22, 2023 6:20pm
FDA conference hall

FDA calls AdComm for Intercept's NASH drug application

Mar 10, 2023 11:18am
FDA

Eying first NASH approval, Intercept gets FDA decision date

Jan 19, 2023 11:30am